These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33214256)

  • 1. Reinfections, still rare, provide clues on immunity.
    de Vrieze J
    Science; 2020 Nov; 370(6519):895-897. PubMed ID: 33214256
    [No Abstract]   [Full Text] [Related]  

  • 2. A first probable case of SARS-CoV-2 reinfection in Colombia.
    Novoa W; Miller H; Mattar S; Faccini-Martínez ÁA; Rivero R; Serrano-Coll H
    Ann Clin Microbiol Antimicrob; 2021 Jan; 20(1):7. PubMed ID: 33435982
    [No Abstract]   [Full Text] [Related]  

  • 3. Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy.
    Ibrahim M; Vegel A; Niu A; Panse K; Chen R; Safah H; Socola F; Luk A; Saba NS
    Leuk Res; 2021 Feb; 101():106514. PubMed ID: 33524639
    [No Abstract]   [Full Text] [Related]  

  • 4. The First Case of Immunity Loss and SARS-CoV-2 Reinfection by the Same Virus Lineage in Amazonia.
    Ferrante L; Livas S; Steinmetz WA; Almeida ACL; Leão J; Vassão RC; Tupinambás U; Fearnside PM; Duczmal LH
    J Racial Ethn Health Disparities; 2021 Aug; 8(4):821-823. PubMed ID: 34155594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding protection from SARS-CoV-2 by studying reinfection.
    Overbaugh J
    Nat Med; 2020 Nov; 26(11):1680-1681. PubMed ID: 33093682
    [No Abstract]   [Full Text] [Related]  

  • 6. [Covid-19 reinfections: what is the clinical relevance?].
    Wiersinga WJ; de Bree GJ
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.
    Tang CY; Wang Y; McElroy JA; Li T; Hammer R; Ritter D; Lidl GM; Webby R; Hang J; Wan XF
    J Med Virol; 2021 Oct; 93(10):5700-5703. PubMed ID: 34170528
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants-first two confirmed events in west Africa.
    Sanyang B; Kanteh A; Usuf E; Nadjm B; Jarju S; Bah A; Bojang A; Grey-Johnson M; Jones JC; Gai A; Sarr C; Sillah F; Wariri O; Oko F; Cerami C; Forrest K; Sey AP; Jallow H; Nwakanma D; Sesay AK; D'Alessandro U; Roca A
    Lancet Glob Health; 2021 Jul; 9(7):e905-e907. PubMed ID: 34090610
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 re-infection.
    Brouqui P; Colson P; Melenotte C; Houhamdi L; Bedotto M; Devaux C; Gautret P; Million M; Parola P; Stoupan D; La Scola B; Lagier JC; Raoult D
    Eur J Clin Invest; 2021 May; 51(5):e13537. PubMed ID: 33675046
    [No Abstract]   [Full Text] [Related]  

  • 10. Proper Assignation of Reactivation in a COVID-19 Recurrence Initially Interpreted as a Reinfection.
    Pérez-Lago L; Martínez-Lozano H; Pajares Díaz JA; Díaz Gómez A; Machado M; Sola-Campoy PJ; Herranz M; Buenestado-Serrano S; Valerio M; Olmedo M; Andrés Zayas C; Comas I; González Candelas F; Bañares R; Catalán P; Muñoz P; García de Viedma D
    J Infect Dis; 2021 Sep; 224(5):788-792. PubMed ID: 34107025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent SARS-CoV-2 RNA positivity after COVID-19: a systematic review and meta-analysis.
    Azam M; Sulistiana R; Ratnawati M; Fibriana AI; Bahrudin U; Widyaningrum D; Aljunid SM
    Sci Rep; 2020 Nov; 10(1):20692. PubMed ID: 33244060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A useful case for comparison, and a new definition of disease-free status.
    Jolobe OMP
    Am J Emerg Med; 2021 Aug; 46():746. PubMed ID: 33036852
    [No Abstract]   [Full Text] [Related]  

  • 13. Confirmed Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant VOC-202012/01.
    Harrington D; Kele B; Pereira S; Couto-Parada X; Riddell A; Forbes S; Dobbie H; Cutino-Moguel T
    Clin Infect Dis; 2021 Nov; 73(10):1946-1947. PubMed ID: 33421056
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioactive lipids in antiviral immunity.
    Theken KN; FitzGerald GA
    Science; 2021 Jan; 371(6526):237-238. PubMed ID: 33446545
    [No Abstract]   [Full Text] [Related]  

  • 15. Is novel coronavirus 2019 reinfection possible? Interpreting dynamic SARS-CoV-2 test results.
    Duggan NM; Ludy SM; Shannon BC; Reisner AT; Wilcox SR
    Am J Emerg Med; 2021 Jan; 39():256.e1-256.e3. PubMed ID: 32703607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible COVID-19 reinfection in a patient with X-linked agammaglobulinaemia.
    Loh SY; Bassett J; Hoodless EJ; Walshaw M
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33664039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy.
    Vitale J; Mumoli N; Clerici P; De Paschale M; Evangelista I; Cei M; Mazzone A
    JAMA Intern Med; 2021 Oct; 181(10):1407-1408. PubMed ID: 34048531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granuloma annulare triggered by SARS-CoV-2 infection. The first reported case.
    García-Gil MF; Monte Serrano J; García García M; Matovelle Ochoa C; Ara-Martín M
    J Dermatol; 2021 Jan; 48(1):e1-e2. PubMed ID: 33169426
    [No Abstract]   [Full Text] [Related]  

  • 20. [First case of SARS-CoV-2 confirmed reinfection in the southern area of Gran Canaria].
    Aroca-Ferri M; Tosco-Núñez T; Hernández-Betancor A; de-Miguel-Martínez I
    Rev Esp Quimioter; 2021 Dec; 34(6):682-683. PubMed ID: 34617431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.